跳至主要内容
临床试验/ISRCTN64639614
ISRCTN64639614进行中(未招募)未知

Standard versus accelerated weaning from non-invasive ventilation (NIV) in chronic obstructive pulmonary disease directed by the NIV outcomes score: a randomised controlled trial

orthumbria Healthcare NHS Foundation Trust0 个研究点目标入组 164 人开始时间: 2022年9月14日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
164

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Clinical diagnosis of Exacerbation of Chronic Obstructive Pulmonary Disease, complicated by acute hypercapnic respiratory failure (pH <7.35 and PaCO2 >6.5 kPa)
  • 2. Age 35 years or over
  • 3. Smoking history of 10 or more pack years
  • 4. Low or medium risk Non-Invasive Ventilation (NIV) Outcomes score
  • 5. Provision of acute NIV for 24 hours or longer
  • 6. Correction of respiratory acidaemia
  • 7. PaCO2 <8 kPa, or PaCO2 8-9 kPa with at least a 20% fall in PaCO2 from pre-NIV baseline value
  • 8. Able to tolerate 60 minutes of unsupported breathing, confirmed by arterial blood gas (ABG)
  • 9. Participants must be randomised within 24 hours of meeting the weaning criteria (based on the time of the qualifying ABG)

排除标准

  • 1. Poor tolerance of NIV likely to limit adherence to protocol
  • 2. Receiving home ventilation on admission, or planned referral for home ventilation on discharge
  • 3. Inability to provide informed consent
  • 4. Failure of another organ requiring level 2 or 3 organ support
  • 5. Clinically significant pulmonary fibrosis
  • 6. Metastatic cancer, advanced haematological malignancy, or other serious comorbidities, which may influence survival or decisions about ventilation within the time frame of the trial (3 months)

研究者

发起方
orthumbria Healthcare NHS Foundation Trust

相似试验

Comparing standard and accelerated weaning from... | 临床试验